Table 3 Induction regimens and proteinuria remission rate of iMN and aMN patients
iMN group (n = 99) | aMN group (n = 105) | p value | |
|---|---|---|---|
Induction regimens | 0.284 | ||
Supportive care only | 6(6.1 %) | 10(9.5 %) | |
GC + CTX | 80(80.8 %) | 77(73.3 %) | |
GC + CNIs | 6(6.1 %) | 13(12.4 %) | |
Other ISTs | 7(7.0 %) | 5(4.8 %) | |
Proteinuria remission rates at 6th month | |||
24hUPE(g/24 h) | 1.62(0.58,6.00) | 2.60(1.15,6.23) | 0.823 |
Complete remission | 18/88(20.5 %) | 10/98(10.2 %) | 0.051 |
Overall remission | 52/88(59.1 %) | 51/98(52.0 %) | 0.334 |
Proteinuria remission rates at endpoint | |||
24hUPE(g/24 h) | 0.23(0.10,2.67) | 0.75(0.14,3.74) | 0.098 |
Complete remission | 54(54.5 %) | 45(42.9 %) | 0.095 |
Overall remission | 73(73.7 %) | 73(69.5 %) | 0.505 |
Renal outcomes | |||
ESRD | 7(7.1 %) | 4(3.8 %) | 0.303 |
primary outcomea | 25(25.3 %) | 21(20.0 %) | 0.370 |